This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHempshire Group (HMPG) 주식 개요는 CBD 대마 담배의 생산 및 유통을 담당하고 있습니다. 자세히 보기HMPG 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6강점지난 1년간 수익이 42.2% 증가했습니다.위험 분석수익이 USD$1m 미만입니다($197K)마이너스 주주 지분의미 있는 시가총액이 없습니다(CA$2M)지난 1년 동안 주주가 크게 희석되었습니다.+ 위험 2건 추가모든 위험 점검 보기HMPG Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCA$Current PriceCA$0.015233.3% 고평가 내재 할인율Est. Revenue$PastFuture-7m289k2016201920222025202620282031Revenue US$197.5kEarnings US$28.9kAdvancedSet Fair ValueView all narrativesThe Hempshire Group, Inc. 경쟁사West Island BrandsSymbol: CNSX:WIBMarket cap: CA$2.0mAion TherapeuticSymbol: CNSX:AIONMarket cap: CA$2.5mCraftport CannabisSymbol: CNSX:CFTMarket cap: CA$2.7mSilo WellnessSymbol: CNSX:SILOMarket cap: CA$1.5m가격 이력 및 성과Hempshire Group 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.01552주 최고가CA$0.0552주 최저가CA$0.005베타0.131개월 변동0%3개월 변동0%1년 변동-72.73%3년 변동n/a5년 변동n/aIPO 이후 변동-94.00%최근 뉴스 및 업데이트공시 • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.공시 • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).공시 • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.더 많은 업데이트 보기Recent updates공시 • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.공시 • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).공시 • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.공시 • Feb 15+ 1 more updateHempshire Group Announces CEO ChangesThe Hempshire Group, Inc. announced that Alex Shegelman, Chief Executive Officer, has advised the Board of Directors that he will retire as Chief Executive Officer effective February 14, 2024, to focus on other commitments. Mr. Shegelman also advised that he will remain on the Board of Directors of the Company. The Board of Directors has appointed Mr. Tom Shuman Chief Executive Officer of Hempshire. Mr. Shuman helped found Hempshire and brings more than 30 years of experience leading CPG sales and marketing teams, both as a founder and executive in various roles. He has extensive experience working across the full sales chain, including with brokers, distributors, wholesalers and retailers, for companies such as Procter & Gamble, Coca-Cola and Dr. Pepper/SevenUp.Reported Earnings • Dec 01Third quarter 2023 earnings released: US$0.006 loss per share (vs US$0.014 loss in 3Q 2022)Third quarter 2023 results: US$0.006 loss per share (improved from US$0.014 loss in 3Q 2022). Revenue: US$49.2k (up 148% from 3Q 2022). Net loss: US$377.4k (loss narrowed 50% from 3Q 2022).Board Change • Nov 16High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.공시 • Sep 13The Hempshire Group, Inc. Announces Management Changes, Effective September 29, 2023The Hempshire Group, Inc. announced the resignation of Chief Financial Officer ("CFO") William Hahn, effective September 29, 2023 who has accepted a new position in a different industry. The Company will appoint Paul Stacey to the role of Interim CFO effective September 29, 2023. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys – a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PriceWaterhouseCoopers.New Risk • Sep 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.3m free cash flow). Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (US$168k revenue). Market cap is less than US$10m (CA$4.47m market cap, or US$3.28m). Minor Risk Shareholders have been diluted in the past year (2.2% increase in shares outstanding).Reported Earnings • Sep 03Second quarter 2023 earnings released: US$0.01 loss per share (vs US$0.075 loss in 2Q 2022)Second quarter 2023 results: US$0.01 loss per share (improved from US$0.075 loss in 2Q 2022). Revenue: US$56.2k (up 187% from 2Q 2022). Net loss: US$609.8k (loss narrowed 85% from 2Q 2022).공시 • Jul 01The Hempshire Group, Inc. Announces Board ChangesThe Hempshire Group, Inc. (formerly Hoist Capital Corp.) announced that Gail Hannon has advised the Board of Directors that she will resign from her role as a director effective June 30, 2023. The Board of Directors has appointed Jason Warnock as a director of Hempshire effective June 30, 2023. Mr. Warnock is an accomplished global sales leader and executive, bringing more than 20 years of experience driving revenue growth and international market strategy for high-profile, Fortune 500 brands. Mr. Warnock has spent the last 16 years in the cannabis, competitive advertising, communications, and emerging technology fields where his work focused on building companies and brands from the ground up, working on strategic mergers and acquisitions, international cannabis regulations and creating communication and advocacy campaigns. He is experienced in delivering consistent and sustainable business results for numerous consumer packaged goods companies, integrating regulatory and international cannabis supply chains and developing high-performance go-to-market sales teams.공시 • Jun 13The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023. Agenda: Annual General and Special Meeting.Reported Earnings • Jun 04First quarter 2023 earnings released: US$0.01 loss per share (vs US$0.063 loss in 1Q 2022)First quarter 2023 results: US$0.01 loss per share (improved from US$0.063 loss in 1Q 2022). Revenue: US$65.8k (up 181% from 1Q 2022). Net loss: US$488.1k (loss narrowed 26% from 1Q 2022).Reported Earnings • Dec 01Third quarter 2022 earnings releasedThird quarter 2022 results: US$0.014 loss per share. Net loss: US$756.8k (flat on 3Q 2021).Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Marty Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 08The Hempshire Group, Inc. Announces Receipt of Regulatory Approval to Import Its Products into the European UnionThe Hempshire Group, Inc. announced receipt of regulatory approval to import its products into the European Union (EU), and the designation of an exclusive European master distributor. Belgian Approval Hempshire announced it has received notice from the Federal Public Health Food Safety and Environment Service of Belgium, an EU member nation, that MOUNTAIN(R) Smokes have been found to conform with European Union Common Entry Gate (EU-CEG) regulations, including regulations governing tobacco and smokable products and the pertinent regulations setting maximum THC levels at under 0.2%. The notice allows MOUNTAIN(R) Smokes to be legally imported into, and commercially sold in, the country. Access to the European Union (EU) As per EU member state reciprocity for the inter-member commercialization of goods, the Belgian authorization allows Hempshire to pursue commercialization and sales across the EU -- provided it complies with individual member nations' specific 'local' regulations, such as packaging in the local language, and inclusion of any locally-required warning labels.Reported Earnings • Sep 02Second quarter 2022 earnings releasedSecond quarter 2022 results: US$0.075 loss per share. Net loss: US$4.05m (flat on 2Q 2021).Board Change • Aug 26No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Martin Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.주주 수익률HMPGCA PharmaceuticalsCA 시장7D0%-3.2%0.7%1Y-72.7%56.5%31.5%전체 주주 수익률 보기수익률 대 산업: HMPG은 지난 1년 동안 56.5%의 수익을 기록한 Canadian Pharmaceuticals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: HMPG은 지난 1년 동안 31.5%를 기록한 Canadian 시장보다 저조한 성과를 냈습니다.주가 변동성Is HMPG's price volatile compared to industry and market?HMPG volatilityHMPG Average Weekly Movementn/aPharmaceuticals Industry Average Movement10.7%Market Average Movement10.1%10% most volatile stocks in CA Market17.5%10% least volatile stocks in CA Market3.8%안정적인 주가: HMPG의 주가는 지난 3개월 동안 Canadian 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine HMPG의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/an/aTom Shumanmountainsmokes.com는 CBD 대마 담배의 생산 및 유통에 종사하는 회사입니다. 이 회사는 마운틴 스모크 브랜드 이름으로 유기농 대마 꽃, 뮬린, 세이지 제품을 제공합니다. 헴프셔 그룹은 캐나다 캘거리에 본사를 두고 있습니다.더 보기The Hempshire Group, Inc. 기초 지표 요약Hempshire Group의 순이익과 매출은 시가총액과 어떻게 비교됩니까?HMPG 기초 통계시가총액CA$2.11m순이익 (TTM)-CA$3.44m매출 (TTM)CA$271.78k7.8x주가매출비율(P/S)-0.6x주가수익비율(P/E)HMPG는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표HMPG 손익계산서 (TTM)매출US$197.49k매출원가US$104.80k총이익US$92.69k기타 비용US$2.59m순이익-US$2.50m최근 보고된 실적Sep 30, 2023다음 실적 발표일해당 없음주당순이익(EPS)-0.018총이익률46.94%순이익률-1,265.05%부채/자본 비율-264.0%HMPG의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/10/12 10:57종가2024/07/15 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스The Hempshire Group, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.
공시 • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.
New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
공시 • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.
New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
공시 • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.
공시 • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.
New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
공시 • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.
New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
공시 • Feb 15+ 1 more updateHempshire Group Announces CEO ChangesThe Hempshire Group, Inc. announced that Alex Shegelman, Chief Executive Officer, has advised the Board of Directors that he will retire as Chief Executive Officer effective February 14, 2024, to focus on other commitments. Mr. Shegelman also advised that he will remain on the Board of Directors of the Company. The Board of Directors has appointed Mr. Tom Shuman Chief Executive Officer of Hempshire. Mr. Shuman helped found Hempshire and brings more than 30 years of experience leading CPG sales and marketing teams, both as a founder and executive in various roles. He has extensive experience working across the full sales chain, including with brokers, distributors, wholesalers and retailers, for companies such as Procter & Gamble, Coca-Cola and Dr. Pepper/SevenUp.
Reported Earnings • Dec 01Third quarter 2023 earnings released: US$0.006 loss per share (vs US$0.014 loss in 3Q 2022)Third quarter 2023 results: US$0.006 loss per share (improved from US$0.014 loss in 3Q 2022). Revenue: US$49.2k (up 148% from 3Q 2022). Net loss: US$377.4k (loss narrowed 50% from 3Q 2022).
Board Change • Nov 16High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
공시 • Sep 13The Hempshire Group, Inc. Announces Management Changes, Effective September 29, 2023The Hempshire Group, Inc. announced the resignation of Chief Financial Officer ("CFO") William Hahn, effective September 29, 2023 who has accepted a new position in a different industry. The Company will appoint Paul Stacey to the role of Interim CFO effective September 29, 2023. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys – a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PriceWaterhouseCoopers.
New Risk • Sep 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.3m free cash flow). Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (US$168k revenue). Market cap is less than US$10m (CA$4.47m market cap, or US$3.28m). Minor Risk Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
Reported Earnings • Sep 03Second quarter 2023 earnings released: US$0.01 loss per share (vs US$0.075 loss in 2Q 2022)Second quarter 2023 results: US$0.01 loss per share (improved from US$0.075 loss in 2Q 2022). Revenue: US$56.2k (up 187% from 2Q 2022). Net loss: US$609.8k (loss narrowed 85% from 2Q 2022).
공시 • Jul 01The Hempshire Group, Inc. Announces Board ChangesThe Hempshire Group, Inc. (formerly Hoist Capital Corp.) announced that Gail Hannon has advised the Board of Directors that she will resign from her role as a director effective June 30, 2023. The Board of Directors has appointed Jason Warnock as a director of Hempshire effective June 30, 2023. Mr. Warnock is an accomplished global sales leader and executive, bringing more than 20 years of experience driving revenue growth and international market strategy for high-profile, Fortune 500 brands. Mr. Warnock has spent the last 16 years in the cannabis, competitive advertising, communications, and emerging technology fields where his work focused on building companies and brands from the ground up, working on strategic mergers and acquisitions, international cannabis regulations and creating communication and advocacy campaigns. He is experienced in delivering consistent and sustainable business results for numerous consumer packaged goods companies, integrating regulatory and international cannabis supply chains and developing high-performance go-to-market sales teams.
공시 • Jun 13The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023. Agenda: Annual General and Special Meeting.
Reported Earnings • Jun 04First quarter 2023 earnings released: US$0.01 loss per share (vs US$0.063 loss in 1Q 2022)First quarter 2023 results: US$0.01 loss per share (improved from US$0.063 loss in 1Q 2022). Revenue: US$65.8k (up 181% from 1Q 2022). Net loss: US$488.1k (loss narrowed 26% from 1Q 2022).
Reported Earnings • Dec 01Third quarter 2022 earnings releasedThird quarter 2022 results: US$0.014 loss per share. Net loss: US$756.8k (flat on 3Q 2021).
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Marty Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 08The Hempshire Group, Inc. Announces Receipt of Regulatory Approval to Import Its Products into the European UnionThe Hempshire Group, Inc. announced receipt of regulatory approval to import its products into the European Union (EU), and the designation of an exclusive European master distributor. Belgian Approval Hempshire announced it has received notice from the Federal Public Health Food Safety and Environment Service of Belgium, an EU member nation, that MOUNTAIN(R) Smokes have been found to conform with European Union Common Entry Gate (EU-CEG) regulations, including regulations governing tobacco and smokable products and the pertinent regulations setting maximum THC levels at under 0.2%. The notice allows MOUNTAIN(R) Smokes to be legally imported into, and commercially sold in, the country. Access to the European Union (EU) As per EU member state reciprocity for the inter-member commercialization of goods, the Belgian authorization allows Hempshire to pursue commercialization and sales across the EU -- provided it complies with individual member nations' specific 'local' regulations, such as packaging in the local language, and inclusion of any locally-required warning labels.
Reported Earnings • Sep 02Second quarter 2022 earnings releasedSecond quarter 2022 results: US$0.075 loss per share. Net loss: US$4.05m (flat on 2Q 2021).
Board Change • Aug 26No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Martin Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
